PHARMBIO KOREA
Pharmbio Korea Company Ltd is a pharmaceutical company. The Company develops drugs for urinary tract infections, diuresis & relaxes urinary tract spasm, gallstones, and difficult digestion.
PHARMBIO KOREA
Social Links:
Industry:
Medical Pharmaceutical
Founded:
1999-05-01
Address:
Seocho, Seoul-t'ukpyolsi, South Korea
Country:
South Korea
Website Url:
http://www.pharmbio.co.kr
Total Employee:
101+
Status:
Active
Contact:
2-587-2551
Technology used in webpage:
SPF Nginx GlobalSign GlobalSign Domain Verification AlphaSSL Korea Telecom LINE WORKS
Similar Organizations
Phapros
Phapros is a pharmaceutical company.
Current Employees Featured
Official Site Inspections
http://www.pharmbio.co.kr
- Host name: 203.245.44.107
- IP address: 203.245.44.107
- Location: South Korea
- Latitude: 37.5112
- Longitude: 126.9741
- Timezone: Asia/Seoul
More informations about "Pharmbio Korea" on Search Engine
(์ฃผ)ํ๊ตญํ๋น์ค - ๊ฑด๊ฐํ ์ถ์ ๋๋ฐ์
(์ฃผ)ํ๊ตญํ๋น์ค - ๊ฑด๊ฐํ ์ถ์ ๋๋ฐ์See details»
Pharmbio paves own way in developing next โฆ
Jun 30, 2022 Pharmbio paves own way in developing next-generation therapeutic agents Blazing its own trail in patient care, Pharmbio Korea has built an impressive portfolio in gastroenterology, general...See details»
Bong Gil Nam โ Chairman & Owner, Pharmbio Korea
Nov 2, 2019 Bong Gil Nam, chairman and owner of Pharmbio Korea, offers his insights on his companyโs importance in differentiating itself from the generic competitors in the market. Mr Nam also explains his strategy โฆSee details»
Pharmbio Korea - Crunchbase Investor Profile & Investments
Details. Industries. Medical. Pharmaceutical. Headquarters Regions Asia-Pacific (APAC) Founded Date May 1, 1999. Operating Status Active. Also Known As ํ๊ตญํ๋น์ค. Legal โฆSee details»
Welcome to Pharmbio Korea Inc.
Pharmbio Korea has increased its investment in R&D from 2% to 8% of its turnover, and has research personnel to support research and development with 12.5% of its total โฆSee details»
Welcome to Pharmbio Korea Inc.
2022-06-30. 220630.jpg. 687. Blazing its own trail in patient care, Pharmbio Korea has built an impressive portfolio in gastroenterology, general surgery, and obstetrics and โฆSee details»
Pharmbio Korea | LinkedIn
Pharmbio Korea | 173 followers on LinkedIn. A pharmaceutical company committed to importing, exporting, manufacturing, and distributing innovative drugs to fullfill unmet โฆSee details»
Pharmbio Korea to have a new production plant in N.
Jul 20, 2020 Home. News & Event. Pharmbio Korea to have a new production plant in N. Chungcheong Prov. Date. 2020.07.20. Views. 440. According to Yonhap News, The city โฆSee details»
Pharmbio Korea - Investments, Portfolio & Company Exits
Mar 31, 2021 About. Pharmbio Korea has invested in Master Meditech on Mar 31, 2021. This investment - Series A - Master Meditech - was valued at. โฉ8B. . Unlock for free. โฆSee details»
Pharmbio Korea Company Profile - Craft
Pharmbio Korea (ํ๊ตญํ๋น์ค) is a pharmaceutical company committed to importing, exporting, manufacturing, and distributing drugs. It focuses on gastrointestinal/general โฆSee details»
Pharmbio Korea - Products, Competitors, Financials, Employees ...
Pharmbio Korea is a pharmaceutical company focused on addressing unmet medical needs through the import, export, manufacturing, and distribution of innovative drugs.See details»
Pharmbio Korea Inc - Company Profile and News - Bloomberg โฆ
10.13. +5.66. APPLE INC. 182.70. -1.63. US TREASURY N/B. 99.03. -0.34. Pharmbio Korea Inc. is a pharmaceutical company. The Company develops drugs for urinary tract โฆSee details»
Alvogen announces exclusive commercialization agreements in โฆ
Alvogen, today announced new exclusive commercialization agreements with PharmBio in South Korea, Kamada in Israel and Jamp in Canada for Teriparatide (PF708) Forteo®, โฆSee details»
Pharmbio Korea - Contacts, Employees, Board Members, โฆ
Investment Firm. Pharmbio Korea. Connect to CRM. Save. Summary Investments People Technology Signals & News Similar Companies. Highlights. Employee Profiles 1. About. โฆSee details»
Welcome to Pharmbio Korea Inc.
Pharmbio Korea Inc. has been awarded โ3 Million dollars-exporting towerโ by the president at the 55th Day of Trade ceremony, which was held at Convention and Exhibition โฆSee details»
Organization | Pharmbio Korea - CDEK
Organization Overview. First Clinical Trial. 2011 NCT01373021. First Marketed Drug. None First NDA Approval. None ... Pharmbio Korea | Pharmbio Korea Co., Ltd. | Pharmbio โฆSee details»
Somatostatin - Pharmbio Korea - AdisInsight - Springer
Feb 18, 2019 Pharmbio Korea is developing somatostatin for the treatment of post hepatectomy liver failure (PHLF). Phase III development was underway in South Korea.See details»
Overview - Overview of Korean Pharmaceutical Industry : KDRA โฆ
Korea Drug Research Association. Overview. Global Pharmaceutical Industry in its operation and innovation activities is now facing serious challenges resulted by mega โฆSee details»
Pharmbio Korea - Crunchbase
Pharmbio Korea is a pharmaceutical company. Start Free Trial . Chrome ExtensionSee details»
PBK M2101 - AdisInsight
Aug 17, 2023 Contact your organizationโs admin about adding this content to your AdisInsight subscription. Buy a PDF version of the profile. Request a free trial. PBK โฆSee details»